AUTHOR=Zeng Jianping , Hua Shushan , Liu Jing , Mungur Rajneesh , He Yongsheng , Feng Jiugeng 

TITLE=Identification of core genes as potential biomarkers for predicting progression and prognosis in glioblastoma

JOURNAL=Frontiers in Genetics

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.928407

DOI=10.3389/fgene.2022.928407

ISSN=1664-8021

ABSTRACT=<p><bold>Background:</bold> Glioblastoma is a common malignant neuroepithelial neoplasm with poor clinical outcomes and limited treatment options. It is extremely important to search and confirm diverse hub genes that are effective in the advance and prediction of glioblastoma.</p><p><bold>Methods:</bold> We analyzed GSE50161, GSE4290, and GSE68848, the three microarray datasets retrieved from the GEO database. GO function and KEGG pathway enrichment analyses for differentially expressed genes (DEGs) were performed using DAVID. The PPI network of the DEGs was analyzed using the Search Tool for the Retrieval of Interacting Genes database and visualized by Cytoscape software. Hub genes were identified through the PPI network and a robust rank aggregation method. The Cancer Genome Atlas (TCGA) and the Oncomine database were used to validate the hub genes. In addition, a survival curve analysis was conducted to verify the correlation between the expression of hub genes and patient prognosis. Human glioblastoma cells and normal cells were collected, and then RT-PCR, Western blot, and immunofluorescence were conducted to validate the expression of the <italic>NDC80</italic> gene. A cell proliferation assay was used to detect the proliferation of glioma cells. The effects of <italic>NDC80</italic> expression on migration and invasion of GBM cell lines were evaluated by conducting scratch and transwell assays.</p><p><bold>Results:</bold> A total of 716 DEGs were common to all three microarray datasets, which included 188 upregulated DEGs and 528 downregulated DEGs. Furthermore, we found that among the common DEGs, 10 hub genes showed a high degree of connectivity. The expression of the 10 hub genes in TCGA and the Oncomine database was significantly overexpressed in glioblastoma compared with normal genes. Additionally, the survival analysis showed that the patients with low expression of six genes (<italic>BIR5C</italic>, <italic>CDC20</italic>, <italic>NDC80</italic>, <italic>CDK1</italic>, <italic>TOP2A</italic>, and <italic>MELK</italic>) had a significantly favorable prognosis (<italic>p</italic> &lt; 0.01). We discovered that <italic>NDC80</italic>, which has been shown to be important in other cancers, also has an important role in malignant gliomas. The RT-PCR, Western blot, and immunofluorescence results showed that the expression level of NDC80 was significantly higher in human glioblastoma cells than in normal cells. Moreover, we identified that NDC80 increased the proliferation and invasion abilities of human glioblastoma cells.</p><p><bold>Conclusion:</bold> The six genes identified here may be utilized to form a panel of disease progression and predictive biomarkers of glioblastoma for clinical purposes. <italic>NDC80</italic>, one of the six genes, was discovered to have a potentially important role in GBM, a finding that needs to be further studied.</p>